DaVita (NYSE:DVA) Stock Rating Lowered by StockNews.com

StockNews.com lowered shares of DaVita (NYSE:DVA - Free Report) from a buy rating to a hold rating in a research note published on Wednesday.

A number of other equities analysts have also weighed in on the company. Cowen reissued a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research report on Friday, February 21st. Finally, Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $166.33.

DaVita Price Performance

Shares of DVA stock traded down $4.37 on Wednesday, reaching $149.37. 1,009,389 shares of the company were exchanged, compared to its average volume of 810,837. DaVita has a 1 year low of $125.64 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The business has a 50-day moving average price of $156.16 and a 200 day moving average price of $157.39. The company has a market cap of $11.95 billion, a price-to-earnings ratio of 13.91, a P/E/G ratio of 1.07 and a beta of 1.04.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities research analysts forecast that DaVita will post 10.76 earnings per share for the current fiscal year.

Institutional Trading of DaVita

Institutional investors and hedge funds have recently bought and sold shares of the stock. Copia Wealth Management purchased a new stake in shares of DaVita in the 4th quarter valued at approximately $30,000. SBI Securities Co. Ltd. acquired a new position in DaVita during the fourth quarter worth $41,000. Coppell Advisory Solutions LLC boosted its position in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares during the period. Quarry LP acquired a new stake in shares of DaVita in the third quarter valued at $60,000. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in shares of DaVita in the 4th quarter valued at $55,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.